XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.2

EARNINGS (LOSS) PER SHARE (Tables)

6 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

Schedule of calculation of earnings (loss) per share

Earnings (loss) per share attributable to Bausch Health Companies Inc. is calculated as follows:

			Three Months Ended June 30,												Six Months Ended June 30,
(in millions, except per share amounts)			2023						2022						2023						2022
Net income (loss) attributable to Bausch Health Companies Inc.			$	26					$	(145)					$	(175)					$	(214)
Basic weighted-average common shares outstanding			364.8						362.2						364.1						361.5
Diluted effect of stock options and RSUs			2.3						—						—						—
Diluted weighted-average common shares outstanding			$	367.1					$	362.2					$	364.1					$	361.5
Earnings (loss) per share attributable to Bausch Health Companies Inc.
Basic			$	0.07					$	(0.40)					$	(0.48)					$	(0.59)
Diluted			$	0.07					$	(0.40)					$	(0.48)					$	(0.59)

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration